Chunghwa Chemical Synthesis & Biotech Co Ltd
TWSE:1762
Wall Street
Price Targets
Price Targets Summary
Chunghwa Chemical Synthesis & Biotech Co Ltd
According to Wall Street analysts, the average 1-year price target for Chunghwa Chemical Synthesis & Biotech Co Ltd is 125 TWD .
Revenue
Forecast
Revenue Estimate
Chunghwa Chemical Synthesis & Biotech Co Ltd
For the last 8 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's revenue is 11%. The projected CAGR for the next 2 years is -9%.
Operating Income
Forecast
Operating Income Estimate
Chunghwa Chemical Synthesis & Biotech Co Ltd
For the last 8 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's operating income is 45%. The projected CAGR for the next 2 years is -31%.
Net Income
Forecast
Net Income Estimate
Chunghwa Chemical Synthesis & Biotech Co Ltd
For the last 8 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's net income is 54%. The projected CAGR for the next 2 years is -33%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Chunghwa Chemical Synthesis & Biotech Co Ltd's stock price target?
Price Target
125
TWD
According to Wall Street analysts, the average 1-year price target for Chunghwa Chemical Synthesis & Biotech Co Ltd is 125 TWD .
What is Chunghwa Chemical Synthesis & Biotech Co Ltd's Revenue forecast?
Projected CAGR
-9%
For the last 8 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's revenue is 11%. The projected CAGR for the next 2 years is -9%.
What is Chunghwa Chemical Synthesis & Biotech Co Ltd's Operating Income forecast?
Projected CAGR
-31%
For the last 8 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's operating income is 45%. The projected CAGR for the next 2 years is -31%.
What is Chunghwa Chemical Synthesis & Biotech Co Ltd's Net Income forecast?
Projected CAGR
-33%
For the last 8 years the compound annual growth rate for Chunghwa Chemical Synthesis & Biotech Co Ltd's net income is 54%. The projected CAGR for the next 2 years is -33%.